SCHEMBL6974883

SCHEMBL6974883

CC1Cc2cc(N)ccc2N(C(=O)CCc2ccc(C#N)cc2)C1

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.41
FFAR1 O14842 3/20 0.36
ALDH1A1 P00352 2/20 0.35
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KDM1A O60341 4/20 0.35
ATAD2 Q6PL18 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
EP300 Q09472 1/20 0.33
RIPK1 Q13546 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6983845 0.85 KCNJ1 (0.45) TP53FFAR1ALDH1A1MAPTMAPK1
SCHEMBL6975443 0.83 TP53 (0.54) TP53ALDH1A1NPC1MAPTMAPK1
SCHEMBL7959087 0.81 TP53 (0.48) TP53ALDH1A1NPC1MAPTMAPK1
SCHEMBL6979722 0.81 TP53 (0.48) TP53ALDH1A1NPC1MAPTMAPK1
SCHEMBL6974890 0.80 DPP8 (0.37) FFAR1ALDH1A1NPC1MAPTMAPK1
SCHEMBL6977052 0.80 TP53 (0.39) TP53ALDH1A1NPC1MAPTMAPK1
SCHEMBL6984463 0.79 POLB (0.44) ALDH1A1
SCHEMBL6983851 0.74 KCNJ1 (0.39) FFAR1ALDH1A1NPC1MAPTMAPK1
SCHEMBL24347338 0.73 HSD17B3 (0.45) ALDH1A1
SCHEMBL6986711 0.72 TSHR (0.45) TP53FFAR1ALDH1A1NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed